Wiley Chambers

1.2k total citations
30 papers, 583 citations indexed

About

Wiley Chambers is a scholar working on Small Animals, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Wiley Chambers has authored 30 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Small Animals, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Wiley Chambers's work include Animal testing and alternatives (7 papers), Veterinary Pharmacology and Anesthesia (4 papers) and Retinal Diseases and Treatments (3 papers). Wiley Chambers is often cited by papers focused on Animal testing and alternatives (7 papers), Veterinary Pharmacology and Anesthesia (4 papers) and Retinal Diseases and Treatments (3 papers). Wiley Chambers collaborates with scholars based in United States, United Kingdom and Australia. Wiley Chambers's co-authors include Raymond N. Kjellberg, Raymond D. Adams, Jonathan C. Horton, W. C. Fowler, Michael W. Belin, Jean Temeck, Haihao Sun, Dianne Murphy, Renan A. Bonnel and Janet A. Springer and has published in prestigious journals such as Ophthalmology, Neurosurgery and Food and Chemical Toxicology.

In The Last Decade

Wiley Chambers

30 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wiley Chambers United States 13 178 136 77 74 70 30 583
Dominic A. Hovsepian United States 6 43 0.2× 120 0.9× 120 1.6× 37 0.5× 7 0.1× 11 432
Yutaro Yamada Japan 14 11 0.1× 36 0.3× 33 0.4× 11 0.1× 63 0.9× 55 514
Michel Polak France 9 46 0.3× 16 0.1× 44 0.6× 44 0.6× 21 0.3× 30 492
Giuseppe Arena Italy 19 62 0.3× 13 0.1× 43 0.6× 13 0.2× 41 0.6× 87 1.1k
Shokoufeh Khanzadeh Iran 12 44 0.2× 29 0.2× 34 0.4× 30 0.4× 11 0.2× 54 391
Michael Nodzenski United States 13 54 0.3× 4 0.0× 116 1.5× 59 0.8× 23 0.3× 21 526
Keiko Yamagami Japan 14 23 0.1× 33 0.2× 14 0.2× 9 0.1× 57 0.8× 60 640
Alpesh Goyal India 13 34 0.2× 13 0.1× 81 1.1× 46 0.6× 7 0.1× 85 688
Mohammed Aljumah Saudi Arabia 14 99 0.6× 40 0.3× 11 0.1× 82 1.1× 14 0.2× 47 569
Ken Nagaya Japan 13 37 0.2× 13 0.1× 114 1.5× 42 0.6× 21 0.3× 54 528

Countries citing papers authored by Wiley Chambers

Since Specialization
Citations

This map shows the geographic impact of Wiley Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiley Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiley Chambers more than expected).

Fields of papers citing papers by Wiley Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wiley Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiley Chambers. The network helps show where Wiley Chambers may publish in the future.

Co-authorship network of co-authors of Wiley Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Wiley Chambers. A scholar is included among the top collaborators of Wiley Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wiley Chambers. Wiley Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chambers, Wiley, et al.. (2022). Association of Daratumumab Use With Ocular Events in a Case Series of US Adults. JAMA Oncology. 8(8). 1209–1209. 3 indexed citations
2.
Kasamon, Yvette L., Hongshan Li, Lian Ma, et al.. (2022). FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma. Pediatric Blood & Cancer. 69(8). e29602–e29602. 24 indexed citations
3.
Lardieri, Allison, Karen Konkel, S. Christopher Jones, et al.. (2021). Pentosan associated retinal pigmentary changes: FDA’s perspective on an emerging postmarketing safety finding. International Urogynecology Journal. 32(11). 2891–2897. 3 indexed citations
4.
Smith, Lois E. H., Ann Hellström, Andreas Stahl, et al.. (2018). Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials. JAMA Ophthalmology. 137(3). 305–305. 13 indexed citations
5.
Sun, Haihao, et al.. (2017). Extrapolation of Efficacy in Pediatric Drug Development and Evidence-based Medicine: Progress and Lessons Learned. Therapeutic Innovation & Regulatory Science. 52(2). 199–205. 49 indexed citations
6.
Fraunfelder, Frederick T., et al.. (2008). Clinical ocular toxicology : drugs, chemicals and herbs. Elsevier eBooks. 4 indexed citations
7.
Harris, Jennifer J., et al.. (2008). Food and Drug Administration approval process for ophthalmic drugs in the US. Current Opinion in Ophthalmology. 19(3). 190–194. 10 indexed citations
8.
Chambers, Wiley, et al.. (2004). Trials and tribulations. Ophthalmology. 111(10). 1801–1806. 6 indexed citations
9.
Chambers, Wiley, et al.. (2004). Trials and tribulations*1A primer on successfully navigating the waters of the Food and Drug Administration. Ophthalmology. 111(10). 1801–1806. 1 indexed citations
10.
Chambers, Wiley, K. Ferguson, & Gordon Prescott. (2000). Continuing medical education by anaesthetists in Scotland: activities, motivation and barriers. Anaesthesia. 55(12). 1192–1197. 17 indexed citations
11.
Stromberg, Kurt, et al.. (1994). Regulatory concerns in the development of topical recombinant ophthalmic and cutaneous wound healing biologics. Wound Repair and Regeneration. 2(3). 155–164. 28 indexed citations
12.
Springer, Janet A., Wiley Chambers, S. Green, et al.. (1993). Number of animals for sequential testing. Food and Chemical Toxicology. 31(2). 105–109. 8 indexed citations
13.
Chambers, Wiley, et al.. (1993). Criteria for in vitro alternatives for the eye irritation test. Food and Chemical Toxicology. 31(2). 81–85. 20 indexed citations
14.
Chambers, Wiley, S. Green, K.C. Gupta, et al.. (1993). Use of ophthalmic topical anaesthetics. Food and Chemical Toxicology. 31(2). 95–98. 7 indexed citations
15.
Gupta, K.C., Wiley Chambers, S. Green, et al.. (1993). An eye irritation test protocol and an evaluation and classification system. Food and Chemical Toxicology. 31(2). 117–121. 11 indexed citations
16.
Hurley, P.M., Wiley Chambers, S. Green, et al.. (1993). Screening procedures for eye irritation. Food and Chemical Toxicology. 31(2). 87–94. 7 indexed citations
17.
Chambers, Wiley, S. Green, K.C. Gupta, et al.. (1993). Scoring for eye irritation tests. Food and Chemical Toxicology. 31(2). 111–115. 18 indexed citations
18.
Horton, Jonathan C., et al.. (1990). Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 27(6). 867–867. 136 indexed citations
19.
Belin, Michael W., W. C. Fowler, & Wiley Chambers. (1988). Keratoconus. Ophthalmology. 95(3). 335–339. 32 indexed citations
20.
Chambers, Wiley, et al.. (1986). EFFECTS OF THE ADDITION OF POTASSIUM TO PRILOCAINE OR BUPIVACAINE. British Journal of Anaesthesia. 58(3). 297–300. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominic A. Hovsepian Breakdown of academic impact, for papers by Yutaro Yamada Breakdown of academic impact, for papers by Michel Polak Breakdown of academic impact, for papers by Giuseppe Arena Breakdown of academic impact, for papers by Shokoufeh Khanzadeh Breakdown of academic impact, for papers by Michael Nodzenski Breakdown of academic impact, for papers by Keiko Yamagami Breakdown of academic impact, for papers by Alpesh Goyal Breakdown of academic impact, for papers by Mohammed Aljumah Breakdown of academic impact, for papers by Ken Nagaya
Rankless by CCL
2026